二代测序在抗菌药物耐药检测中的应用
本文综述二代测序(NGS)在抗菌药物耐药(AMR)检测中的主要测序策略及临床应用,评估各平台优缺点。传统表型方法通量低且难以用于混合或不可培养病原体,NGS可高分辨率基因分型。尽管成本高、技术复杂且基因型-表型关联不完美,AI辅助分析、耐药基因数据库和便携平台正推动其临床转化。
要点
- NGS可高分辨率基因分型检测耐药,弥补传统培养药敏通量低和难培养病原体局限。
- NGS耐药检测仍面临高成本、技术复杂及基因型-表型关联不完美等挑战。
- AI辅助分析、耐药基因数据库和便携测序平台正推动NGS向临床转化。
核心结论
- NGS基于的诊断有望成为精准抗菌治疗和全球AMR监测的必备工具。
研究设计与样本
- 本文为综述,概述主要测序策略并评估其在不同病原体耐药检测中的临床应用,同时批判性分析各平台优势与局限。
主要发现
- 传统表型方法如培养药敏通量低,对混合或不可培养病原体适用性有限。
- NGS技术通过高分辨率基因分型改变了耐药检测方式。
- AI辅助分析、耐药基因数据库和便携测序平台正逐步缩小研究与临床实施间的差距。
临床怎么用
- NGS可用于精准抗菌治疗和全球AMR监测,但需考虑成本、技术复杂性和基因型-表型关联不完美。
局限性
- NGS耐药检测仍面临高成本、技术复杂性和基因型-表型关联不完美等持续挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antimicrobial resistance (AMR) is increasing on a global scale, necessitating the development of diagnostic tools that are more accurate, comprehensive, and rapid. Traditional phenotypic methods, such as culture-based antimicrobial susceptibility testing, are constrained by low throughput and limited applicability to polymicrobial or non-culturable pathogens. In contrast, Next-Generation Sequencing (NGS) technologies have transformed resistance detection by enabling high-resolution genotyping. This review provides a comprehensive overview of major sequencing strategies and evaluates their clinical applications for detecting drug resistance across diverse pathogens, while critically examining the advantages and limitations of each platform. Despite ongoing challenges including high cost, technical complexity, and imperfect genotype-phenotype correlations, recent advances in artificial intelligence (AI)-assisted analysis, resistance gene databases, and portable sequencing platforms are progressively bridging the gap between research and clinical implementation. NGS-based diagnostics are poised to become indispensable tools for precision antimicrobial therapy and global AMR surveillance.
引用
- Wang H, Ye C, Jiang H, et al. Application of next-generation sequencing in the detection of antimicrobial resistance. Clin Chim Acta. 2025. PMID: 40744242. doi:10.1016/j.cca.2025.120520
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。